Sironax
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 5th Ave Fl 4, Waltham, Massachusetts...Website
www.sironax.comRevenue
$60.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sironax
Sironax pis emerging leader at the forefront of innovating transformational therapies that address the root cause of age-related degenerative disease. The company is headquartered in China.Explore more
Sironax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sironax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sironax
Check out if Sironax is spiking on competitors!
Earning: See what the market has to say on Sironax recently announced quarterly report
Check if Sironax has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sironax has new funding data
Product Launch: Get notified when Sironax launches new products
Website visits: Recent activity has been detected on your website
Click to see if Sironax had a recent Job posting/layoffs
Sironax, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Sironax
Find 3 more new buyers
Company Profile Activity
Activity Insights
Sironax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sironax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sironax.
Sironax financials insights
Gather financial insights about Sironax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series B
$200M
Sironax Tech Stack
A closer look at the technologies used by Sironax
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Sironax is hiring in C-Suite for the first time in 12 months. Areas of expertise include: Quality Culture, Regulatory Frameworks, FDA Regulations, Quality Management Systems, Safety Management Systems, Compliance Implementation, and Lifecycle Management.
Hiring Plans
Open Position
Open Position
Sironax News & Media
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
Poster presentation scheduled for May 30, 1:30-4:30 PM CDT Poster presentation scheduled for May 30, 1:30-4:30 PM CDTSironax Appoints Clive Wang to Board of Directors
WALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases, today announced that Clive Wang, Managing Director at YF Capital, has been appointed to its Board of Directors. Mr. Wang brings significant investment and operational leadership in driving the growth of a broad variety of life science companies.Sironax Announces Upcoming Poster Presentation on NAMPT Activation
NAD for Health conference, Copenhagen, March 23-25, 2026 NAD for Health conference, Copenhagen, March 23-25, 2026Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
Society for Neuroscience Annual Meeting, November 15-19, San Diego, CA Society for Neuroscience Annual Meeting, November 15-19, San Diego, CA
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Sironax
Sign Up For FreeTo access detailed company insights
Sironax pis emerging leader at the forefront of innovating transformational therapies that address the root cause of age-related degenerative disease. The company is headquartered in China.... Read More
